ITGAX and metastatic melanoma: In metastatic melanoma, we observed ITGAX (alias CD11c), a marker expressed on myeloid cells with a well-known impact on classical and monocytic dendritic cell function [71], is more frequently mutated in non-T cell-inflamed tumors.